MedicarePartD.guide

A non-government resource built from CMS public data

MESALAMINE 400 mg Capsule, Delayed Release

Coverage in Connecticut, Massachusetts, Rhode Island and Vermont (CMS PDP Region 02).

4 of 11 stand-alone Part D plans in Connecticut, Massachusetts, Rhode Island and Vermont cover this drug on tier 4.

2 of 4 plans apply a prior authorization, step therapy or quantity limit.

88 Medicare Advantage plans in CT, MA, RI do cover it

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. CT: 30 plans · MA: 53 plans · RI: 5 plans.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
Blue MedicareRx Value Plus (PDP)$20.70/mo premium · $615.00 deductible4Non-Preferred Drug32%32%$1.4967$26.9418 units
  • Quantity limit 18 per 30 days
Wellcare Classic (PDP)$21.70/mo premium · $615.00 deductible4Non-Preferred Drug29%29%$2.1670—None
SilverScript Choice (PDP)$32.70/mo premium · $615.00 deductible4Non-Preferred Drug35%35%$3.2301—None
Blue MedicareRx Premier (PDP)$238.60/mo premium · $0.00 deductible4Non-Preferred Drug35%35%$1.4967$26.9418 units
  • Quantity limit 18 per 30 days

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →